project id: TCGA-BRCA; case submitter id: TCGA-AR-A2LE; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.1; age at index: 69; days to birth: -25499; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1932; age at diagnosis: 25499; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 5062.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2001; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3755; days to sample procurement: 0; initial weight: 320.0; portion submitter id: TCGA-AR-A2LE-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 92.0;